Vanguard Group Inc. Sells 138,597 Shares of Sabra Healthcare REIT, Inc. $SBRA

Vanguard Group Inc. lowered its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 0.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 34,852,559 shares of the real estate investment trust's stock after selling 138,597 shares during the quarter. Vanguard Group Inc. owned approximately 14.65% of Sabra Healthcare REIT worth $608,874,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. State of Michigan Retirement System lifted its stake in Sabra Healthcare REIT by 1.1% in the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock valued at $990,000 after acquiring an additional 600 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in Sabra Healthcare REIT by 0.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock valued at $1,158,000 after acquiring an additional 600 shares during the period. Harbor Capital Advisors Inc. increased its position in Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after buying an additional 642 shares during the period. Diversify Advisory Services LLC increased its position in Sabra Healthcare REIT by 5.7% during the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock worth $226,000 after acquiring an additional 689 shares during the period. Finally, IFP Advisors Inc increased its holdings in Sabra Healthcare REIT by 16.2% in the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock valued at $88,000 after buying an additional 706 shares during the period. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock traded up $0.21 during trading on Monday, hitting $18.67. 560,524 shares of the stock traded hands, compared to its average volume of 2,449,666. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock has a market cap of $4.48 billion, a price-to-earnings ratio of 24.55, a PEG ratio of 1.53 and a beta of 0.86. The firm's fifty day moving average is $18.33 and its 200-day moving average is $17.62. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business's revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business earned $0.36 earnings per share. Research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.4%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's payout ratio is presently 157.89%.

Insiders Place Their Bets

In other news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities upped their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.00.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.